Zhejiang Jolly Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This analysis of Zhejiang Jolly Pharmaceutical Co Ltd employs data from across the internet and also from public disclosures by Zhejiang Jolly Pharmaceutical Co Ltd. The Disclosure rating includes 17 UN SDGs including: 'Affordable & Clean Energy', 'Reduced Inequalities' and 'Partnerships for the Goals'. Full ESG assessment of Zhejiang Jolly Pharmaceutical Co Ltd are reached by signing up for free.
Zhejiang Jolly Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Zhejiang Jolly Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Zhejiang Jolly Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Zhejiang Jolly Pharmaceutical Co Ltd report the average age of the workforce?
Does Zhejiang Jolly Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Zhejiang Jolly Pharmaceutical Co Ltd offer flexible work?
Does Zhejiang Jolly Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Zhejiang Jolly Pharmaceutical Co Ltd conduct supply chain audits?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Zhejiang Jolly Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose water use targets?
Does Zhejiang Jolly Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Zhejiang Jolly Pharmaceutical Co Ltd have a product recall in the last two years?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Zhejiang Jolly Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Zhejiang Jolly Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose parental leave metrics?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Zhejiang Jolly Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Zhejiang Jolly Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Zhejiang Jolly Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose its waste policy?
Does Zhejiang Jolly Pharmaceutical Co Ltd report according to TCFD requirements?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose energy use targets?
Does Zhejiang Jolly Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Zhejiang Jolly Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Zhejiang Jolly Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co., Ltd. in 1998. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 and is based in Huzhou, China.